BIODEXA PHARMACEUTICALS PLC

Historical 13F Holders

Symbol
BDRX
CUSIP
59564R880
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 59564R880 since 12/18/2024, largest first.

Filer % of Class Filed
Sabby Management, LLC 13G
9.9% 1/20/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Armistice Capital, LLC 13G
Amended under CUSIP 59564R872 on 5/15/2026
10.0% 2/17/2026
Event 12/31/2025
C/M Capital Partners, LP 13G/A
0% 11/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 3.00 $8.00
2026 Q1 7 369 k $228 k
2025 Q4 8 305 k $693 k
2025 Q3 4 8.40 k $55.8 k